What are the diagnostic criteria and treatment options for Irritable Bowel Syndrome (IBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Irritable Bowel Syndrome (IBS)

IBS should be diagnosed using the Rome III criteria, which requires recurrent abdominal pain or discomfort at least 3 days per month in the past 3 months, associated with two or more of: improvement with defecation, onset associated with change in stool frequency, or onset associated with change in stool form. 1

Diagnostic Criteria Evolution

The diagnostic approach to IBS has evolved through several iterations of criteria:

Manning Criteria

  • Abdominal pain relieved by defecation
  • Looser stools with onset of pain
  • More frequent stools with onset of pain
  • Abdominal distension
  • Passage of mucus in stools
  • Sensation of incomplete evacuation 1

Rome II Criteria

12 weeks or more in the last 12 months of abdominal discomfort or pain with two of three features:

  1. Relieved by defecation
  2. Associated with change in stool frequency
  3. Associated with change in stool consistency 1

Rome III Criteria (Current Standard)

Recurrent abdominal pain or discomfort at least 3 days per month in the past 3 months, associated with two or more of:

  • Improvement with defecation
  • Onset associated with change in frequency of stool
  • Onset associated with change in form of stool 1, 2

Note: Criteria must be fulfilled for the past 3 months with symptom onset at least 6 months before diagnosis.

Making the Diagnosis

Positive Diagnostic Approach

  1. Identify typical symptoms matching Rome criteria
  2. Perform normal physical examination
  3. Confirm absence of alarm features:
    • Weight loss
    • Rectal bleeding
    • Nocturnal symptoms
    • Anemia 1

Supportive Features

The diagnosis is more likely if:

  • Patient is female
  • Age <45 years
  • History >2 years
  • Previous frequent consultations for non-gastrointestinal symptoms 1

When to Consider Further Testing

Further investigation is warranted if:

  • Symptoms are atypical
  • History is short (<6 months)
  • Patient is over 45 years old
  • Alarm features are present 1

Recommended Tests in Selected Cases

  • Celiac disease screening
  • Sigmoidoscopy (if colonic symptoms present)
  • Thyroid function tests
  • Stool microscopy
  • Lactose tolerance testing (if substantial milk consumption)
  • Colonoscopy or barium enema (for patients >45 years or with family history of colon cancer) 1

IBS Subtypes

IBS is classified into subtypes based on predominant stool pattern:

  • IBS with constipation (IBS-C): Hard stools >25% of the time, loose stools <25% of the time
  • IBS with diarrhea (IBS-D): Loose stools >25% of the time, hard stools <25% of the time
  • Mixed IBS (IBS-M): Both hard and loose stools >25% of the time 2, 3

Common Pitfalls to Avoid

  1. Overinvestigation: Once a functional diagnosis is established, the incidence of new non-functional diagnoses is extremely low 1

  2. Ignoring red flags: Age >50 at symptom onset, short history, weight loss, nocturnal symptoms, family history of colon cancer, anemia, or rectal bleeding require further investigation 2

  3. Confusing with other functional disorders: Diarrhea or constipation without abdominal pain are not IBS but separate functional disorders 2

  4. Treating only one aspect: For IBS-C, treating constipation without addressing pain is inadequate 2

  5. Repetitive testing: Avoid anxiety-provoking serial testing; perform necessary tests at the first visit 1

Treatment Approach

Treatment should target the predominant symptoms:

For All IBS Patients

  • Positive diagnosis with clear explanation
  • Reassurance about benign prognosis
  • Listening to patient concerns
  • Lifestyle modifications (stress reduction, physical activity) 1, 4

For IBS-C

  • First-line: Osmotic laxatives
  • Second-line: Stimulant laxatives, secretagogues 2, 5

For IBS-D

  • First-line: Anti-diarrheal drugs (loperamide)
  • Second-line: 5-HT3 antagonists, eluxadoline, rifaximin 5, 6

For Abdominal Pain

  • First-line: Antispasmodics
  • Second-line: Low-dose tricyclic antidepressants (e.g., amitriptyline) 5

The prognosis depends on the length of history and presence of chronic life stressors, with longer history and ongoing life stresses associated with poorer outcomes 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An evidence-based update on the diagnosis and management of irritable bowel syndrome.

Expert review of gastroenterology & hepatology, 2025

Research

Current gut-directed therapies for irritable bowel syndrome.

Current treatment options in gastroenterology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.